tofenacin has been researched along with orphenadrine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Capstick, N; Pudney, H | 1 |
| Altamura, AC; De Novellis, F; Mauri, MC; Percudani, M; Vampini, V | 1 |
| Albani, F; Baruzzi, A; Contin, M; Riva, R | 1 |
| Crome, P | 1 |
| Bast, A; Noordhoek, J; Savenije-Chapel, EM; van Kemenade, FA | 1 |
| Bast, A; Noordhoek, J; Savenije-Chapel, EM; Scheefhals, LW; van Kemenade, FA | 1 |
1 review(s) available for tofenacin and orphenadrine
| Article | Year |
|---|---|
Antidepressant overdosage.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Brompheniramine; Flupenthixol; Humans; Iprindole; Lithium; Mianserin; Monoamine Oxidase Inhibitors; Nomifensine; Orphenadrine; Parasympatholytics; Pyridoxine; Trazodone; Tryptophan; Viloxazine; Zimeldine | 1982 |
1 trial(s) available for tofenacin and orphenadrine
| Article | Year |
|---|---|
A comparative trial of orphenadrine and tofenacin in the control of depression and extrapyramidal side-effects associated with fluphenazine decanoate therapy.
Topics: Clinical Trials as Topic; Depression; Fluphenazine; Humans; Orphenadrine; Parkinson Disease, Secondary | 1976 |
4 other study(ies) available for tofenacin and orphenadrine
| Article | Year |
|---|---|
Residual neuroleptic-induced parkinsonian symptoms in schizophrenia. A naturalistic study with orphenadrine.
Topics: Adult; Aged; Female; Haloperidol; Humans; Male; Middle Aged; Orphenadrine; Parkinson Disease, Secondary; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1989 |
Simple and rapid GLC method for the determination of orphenadrine in human plasma.
Topics: Chromatography, Gas; Humans; Orphenadrine | 1987 |
Product inhibition in orphenadrine metabolism as a result of a stable cytochrome P-450-metabolic intermediate complex formed during the disposition of mono-N-desmethylorphenadrine (tofenacine) in the rat.
Topics: Animals; Cytochrome P-450 Enzyme System; In Vitro Techniques; Male; Microsomes, Liver; Orphenadrine; Phenobarbital; Rats; Rats, Inbred Strains | 1983 |
Effect of multiple administration of orphenadrine or mono-N-desmethylorphenadrine on cytochrome P-450 catalyzed reactions in the rat.
Topics: Aminopyrine; Animals; Cytochrome P-450 Enzyme System; In Vitro Techniques; Kinetics; Male; Microsomes, Liver; Mixed Function Oxygenases; Orphenadrine; Rats; Rats, Inbred Strains | 1983 |